Edge Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Edge Asset Management's EW Position: Q1 2017 in Review
Edge Asset Management increased its Edwards Lifesciences (EW) stake by 12% in Q1 2017, buying an estimated $2.27M and bringing the position to 669,561 shares worth $21M. The position accounts for 0.16% of the portfolio, ranked #163.
Edge Asset Management first reported a position in EW in Q2 2013 and has held it in 16 quarters since. The position peaked at $23.3M in Q3 2016. 691 funds tracked by Wall St. Rank hold EW as of Q1 2017.
- Edge Asset Management held 669,561 shares of Edwards Lifesciences worth $21M as of Q1 2017.
- Edge Asset Management bought 72,603 Edwards Lifesciences shares in Q1 2017, an estimated $2.27M.
- Edwards Lifesciences made up 0.16% of Edge Asset Management's portfolio in Q1 2017, its #163 holding.
- Edge Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 16 quarters since.
- Edge Asset Management's Edwards Lifesciences position peaked at $23.3M in Q3 2016.
- 691 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.
Based on Edge Asset Management's 13F filing for Q1 2017, filed 11 May 2017.